These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3071240)

  • 1. Review of serum lipids and apolipoproteins in risk-assessment of coronary heart disease.
    Rifai N; Chapman JF; Silverman LM; Gwynnes JT
    Ann Clin Lab Sci; 1988; 18(6):429-39. PubMed ID: 3071240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of lipid and lipoprotein profiles in risk assessment and therapy.
    Ballantyne CM; Hoogeveen RC
    Am Heart J; 2003 Aug; 146(2):227-33. PubMed ID: 12891189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoproteins and long-term prognosis in coronary heart disease patients.
    Benderly M; Boyko V; Goldbourt U
    Am Heart J; 2009 Jan; 157(1):103-10. PubMed ID: 19081405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
    Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
    Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum levels of lipids and apolipoproteins in angiographycally defined ischemic heart disease.
    Shima K; Tanaka A; Ejiri N; Maezawa H
    Bull Tokyo Med Dent Univ; 1985 Dec; 32(4):169-77. PubMed ID: 3865743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-converting enzyme gene polymorphism, lipids, and apolipoproteins in menopausal women on hormone replacement therapy.
    Cubrilo-Turek M; Sertić J; Duraković Z
    Acta Med Croatica; 2001; 55(4-5):161-7. PubMed ID: 12398019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative characteristics of the basic blood lipid and apolipoprotein spectrum in groups of patients from Moscow and Bordeaux with ischemic heart disease].
    Perova NV; Bonne Zh; Nechaev AS; Shcherbakova IA; Metel'skaia VA
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1986; 9(1):66-72. PubMed ID: 3707722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New diagnostic tests for assessing coronary heart disease risk.
    Naito HK
    Prog Clin Biol Res; 1988; 255():49-62. PubMed ID: 3277204
    [No Abstract]   [Full Text] [Related]  

  • 9. Apolipoproteins as markers and managers of coronary risk.
    Chan DC; Watts GF
    QJM; 2006 May; 99(5):277-87. PubMed ID: 16504986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlates and consequences of diffuse atherosclerosis in men with coronary heart disease. Veterans Affairs High-Density Lipoprotein Intervention Trial Study Group.
    Wilt TJ; Rubins HB; Collins D; O'Connor TZ; Rutan GH; Robins SJ
    Arch Intern Med; 1996 Jun; 156(11):1181-8. PubMed ID: 8639012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipids, lipoproteins and apolipoproteins among turks, and impact on coronary heart disease.
    Onat A
    Anadolu Kardiyol Derg; 2004 Sep; 4(3):236-45. PubMed ID: 15355827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein-B, low-density lipoprotein cholesterol, and the long-term risk of coronary heart disease in men.
    St-Pierre AC; Cantin B; Dagenais GR; Després JP; Lamarche B
    Am J Cardiol; 2006 Apr; 97(7):997-1001. PubMed ID: 16563904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality specifications and the assessment of the biochemical risk of atherosclerosis.
    Rifai N; Warnick GR
    Clin Chim Acta; 2004 Aug; 346(1):55-64. PubMed ID: 15234636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent corticosteroid use and recent disease activity: independent determinants of coronary heart disease risk factors in systemic lupus erythematosus?
    Karp I; Abrahamowicz M; Fortin PR; Pilote L; Neville C; Pineau CA; Esdaile JM
    Arthritis Rheum; 2008 Feb; 59(2):169-75. PubMed ID: 18240259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Introduction to risk assessment and serum risk markers for the prevention of coronary heart disease and other potential conditions that impact men's health, part I: what do I tell my patients?
    Moyad MA
    Urol Clin North Am; 2004 May; 31(2):195-8. PubMed ID: 15123398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total serum cholesterol levels and mortality risk as a function of age. A report based on the Framingham data.
    Kronmal RA; Cain KC; Ye Z; Omenn GS
    Arch Intern Med; 1993 May; 153(9):1065-73. PubMed ID: 8481074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Apolipoproteins A-1 and B of the blood plasma and apolipoproteins A-1 of 2 high-density lipoprotein subclasses in ischemic heart disease patients with various lipoprotein spectra].
    Metel'skaia VA; Perova NV; Chernysheva NP; Kurdanov KhA; Polesskiĭ VA
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1983; 6(1):83-9. PubMed ID: 6407489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Plasma lipoproteins and apolipoproteins. Value of their determination in the detection of coronary atherosclerosis. Comparison with data supplied by coronarography].
    Fruchart JC; Bertrand M; Parra H; Gentilini JL; Boniface B; Boniface M
    Nouv Presse Med; 1982 Nov; 11(47):3491-4. PubMed ID: 6818524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High risk for coronary heart disease in Thiruvananthapuram city: a study of serum lipids and other risk factors.
    Joseph A; Kutty VR; Soman CR
    Indian Heart J; 2000; 52(1):29-35. PubMed ID: 10820930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired protection against diabetes and coronary heart disease by high-density lipoproteins in Turks.
    Onat A; Can G; Ayhan E; Kaya Z; Hergenç G
    Metabolism; 2009 Oct; 58(10):1393-9. PubMed ID: 19570555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.